Iron deficiency in cancer patients. - Wikidata - awgldk - TriplyDB

Iron deficiency in cancer patients.

Iron deficiency in cancer patients.

http://www.wikidata.org/entity/Q37429231

about

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.Adjusting thresholds of serum ferritin for iron deficiency: a moving target.Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery

P2860

Q39371536-44F60E0B-617B-4383-8A08-3E42925EFAAC Q41501228-8000B22F-2EAC-44FB-9AC0-FFA72B1630F0 Q57173976-243075FE-D12C-44AA-87DC-66DC3F49A483

P2860

Iron deficiency in cancer patients.

http://www.wikidata.org/entity/Q37429231

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Iron deficiency in cancer patients.

@en

Iron deficiency in cancer patients.

@nl

type

label

Iron deficiency in cancer patients.

@en

Iron deficiency in cancer patients.

@nl

prefLabel

Iron deficiency in cancer patients.

@en

Iron deficiency in cancer patients.

@nl

P1433

Q37429231-CB51CB9A-873D-46F4-99D5-8A53D934970B

P1476

Q37429231-7381156C-2C36-4F64-AC33-1E2F369613B3

P2093

Q37429231-0B79E22F-2B2D-4650-A284-08DF2749202F

P2860

Q37429231-07313881-CC6C-454E-B5A2-63C498CFC803

Q37429231-07C3623C-7861-40D3-8609-0BD1F8FE6F22

Q37429231-1DB5A034-2922-48C6-876B-EF462BB5451E

Q37429231-21EFF418-F02F-4D48-91AD-EB0D65A291ED

Q37429231-2F1B6221-4197-48A6-B085-87C3682C314B

Q37429231-3516CE27-6B70-4219-8732-833142ADB14D

Q37429231-47BDE1C0-F03B-49B6-97B6-7B882117DFA6

Q37429231-49233F70-CE8D-46F2-9501-3DE1A8416A6D

Q37429231-671C0AE4-266D-4E1A-86AD-27219A19F6B4

Q37429231-6E9FA664-36D4-46AB-BC63-BA57903BD3D3

P304

Q37429231-F9BA7D4E-1DF2-4DE2-A097-8A153512FBF4

P31

Q37429231-D76BC529-6B58-472C-A918-F46E1E2C4AB0

P356

Q37429231-36ED81D7-4379-43BC-A405-E0DBAF36749F

P433

Q37429231-A562D05E-DA04-47BA-8D0B-25E24962D7CF

P478

Q37429231-C0C4DD87-D93C-4A76-BC71-3DB18A2CF2E8

P577

Q37429231-1B9636B9-2445-40F8-9351-5D62BCF2AFBA

P698

Q37429231-38CF9E02-3A6C-4CFB-82CB-6F054738AD92

P932

Q37429231-6A77D55C-25C4-40ED-B2AA-7312E899FFEF

P356

J.BJHH.2016.05.009

P1433

Revista brasileira de hematologia e hemoterapia

P1476

Iron deficiency in cancer patients.

@en

P2093

Flávio Augusto Naoum

http://www.w3.org/2001/XMLSchema#string

P2860

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

Regulation of cellular iron metabolism

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.

The pharmacokinetics and pharmacodynamics of iron preparations.

Anemia of chronic disease.

The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients.

Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia

Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.

Iron metabolism and iron supplementation in cancer patients

P304

325-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJHH.2016.05.009

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27863761

http://www.w3.org/2001/XMLSchema#string

P932

5119669

http://www.w3.org/2001/XMLSchema#string